Cosmos Health (NASDAQ:COSM) Shares Down 2.2%

Shares of Cosmos Health Inc. (NASDAQ:COSM) fell 2.2% on Wednesday . The company traded as low as $0.65 and last traded at $0.67. 21,434 shares changed hands during trading, a decline of 92% from the average session volume of 254,787 shares. The stock had previously closed at $0.68.

Wall Street Analysts Forecast Growth

Separately, Taglich Brothers restated a “speculative buy” rating on shares of Cosmos Health in a research note on Tuesday, February 20th.

Cosmos Health Trading Down 2.2 %

The business has a 50 day simple moving average of $0.69 and a 200-day simple moving average of $0.95. The company has a quick ratio of 1.79, a current ratio of 2.06 and a debt-to-equity ratio of 0.08.

Insider Activity at Cosmos Health

In other news, CEO Grigorios Siokas bought 60,000 shares of the stock in a transaction that occurred on Friday, February 16th. The shares were purchased at an average cost of $0.83 per share, with a total value of $49,800.00. Following the completion of the acquisition, the chief executive officer now directly owns 1,394,597 shares in the company, valued at $1,157,515.51. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 18.74% of the company’s stock.

Institutional Investors Weigh In On Cosmos Health

A hedge fund recently bought a new stake in Cosmos Health stock. Armistice Capital LLC bought a new position in Cosmos Health Inc. (NASDAQ:COSM) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 1,334,937 shares of the company’s stock, valued at approximately $1,882,000. Armistice Capital LLC owned about 7.89% of Cosmos Health as of its most recent filing with the Securities and Exchange Commission. Institutional investors and hedge funds own 12.61% of the company’s stock.

About Cosmos Health

Cosmos Health Inc provides proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, cosmetics, nursery, health care and baby products, and medical devices. Its nutraceutical product portfolio includes Sky Premium Life and Mediterranation. The company serves wholesale pharmaceutical distributors and independent retail pharmacies.